What type of study is this?

This is a Machine Learning study (also classified as: Molecular Docking, In Vitro Study).

September 10, 2025ACS OmegaOpen Access

Discovery of Potential Tyrosinase Inhibitors via Machine Learning and Molecular Docking with Experimental Validation of Activity and Skin Permeation

View Full Paper

Ask AI

Bookmark

Authors

Experimental validation reveals novel skin permeable tyrosinase inhibitors, suggesting improved efficacy over conventional agents.

Three new tyrosinase inhibitors demonstrated significantly higher activity than arbutin.
Rhodanine-3-propionic acid showed the most potent inhibition with an IC50 of 0.7349 mM.
Machine learning models effectively predicted tyrosinase inhibitor activity from compound libraries.
Transdermal tests confirmed these compounds had better skin permeability than current formulations.

Kang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark